Le Gargasson Jean-Bernard, Nyonator Frank K, Adibo Moses, Gessner Bradford D, Colombini Anaïs
Agence de Médecine Préventive, Paris, France.
Ghana Health Service, Accra, Ghana.
Vaccine. 2015 May 7;33 Suppl 1:A40-6. doi: 10.1016/j.vaccine.2014.12.081.
Limited knowledge exists on the full cost of routine immunization in Africa. Ghana was the first African country to simultaneously introduce rotavirus, pneumococcal and measles second-dose vaccines. Given their high price, it would be beneficial to Ghanaian health authorities to know the true cost of their introduction.
The economic costs of routine immunization for 2011 and the incremental costs of new vaccines were assessed as part of a multi-country study on costing and financing of routine immunization known as the Expanded Program on Immunization Costing (EPIC). Immunization delivery costs were evaluated at the local facility, district, regional, and central levels. Stratified random sampling was used for district and facility selection. We calculated the allocation of nationwide costs to the four health-system levels.
The total aggregated national costs for routine immunization - including vaccine costs - equaled US$ 53.5 million during 2011 (including central, regional, and district costs); this equated to US$ 60.3 per fully immunized child (FIC) when counting vaccine costs, or US$ 48.1 without. National immunization program delivery costs were allocated as follows: local facility level, 85% of total national cost; district, 11%; central, 2% and regional, 2%. Salaried labor represented 61% of total costs, and vaccines represented 17%. For new vaccine introduction, programmatic start-up costs amounted to US$ 3.9 million, primarily due to salaried labor (66%). The mean facility-level cost per vaccine dose administered in a routine immunization program was US$ 5.1 (with a range of US$ 2.4-7.8 depending on facility characteristics) and US$ 3.7 for delivery costs.
We identified a high cost per fully immunized child, mostly due to non-vaccine costs at the facility level, which indicates that immunization program financing - whether national or donor-driven - must take a broad viewpoint. This substantial variation in overall costs emphasizes the additional effort associated with reaching children in various settings.
关于非洲常规免疫的全部成本,人们了解有限。加纳是首个同时引入轮状病毒疫苗、肺炎球菌疫苗和麻疹二剂次疫苗的非洲国家。鉴于这些疫苗价格高昂,了解引入这些疫苗的真实成本对加纳卫生当局有益。
作为一项关于常规免疫成本核算与筹资的多国研究(即扩大免疫规划成本核算研究,简称EPIC)的一部分,评估了2011年常规免疫的经济成本以及新疫苗的增量成本。在地方机构、地区、区域和中央各级评估了免疫接种服务成本。采用分层随机抽样选择地区和机构。我们计算了全国成本在四个卫生系统层级的分配情况。
2011年常规免疫的全国总成本(包括疫苗成本)总计5350万美元(包括中央、区域和地区成本);计算疫苗成本时,每名完全免疫儿童(FIC)的成本为60.3美元,不计算疫苗成本时为48.1美元。国家免疫规划服务成本的分配如下:地方机构层级占全国总成本的85%;地区占11%;中央占2%;区域占2%。薪资劳动力占总成本的61%,疫苗占17%。对于新疫苗的引入,项目启动成本达390万美元,主要原因是薪资劳动力(占66%)。在常规免疫项目中,每剂疫苗的平均机构层级成本为5.1美元(根据机构特征,范围在2.4 - 7.8美元之间),服务成本为3.7美元。
我们发现每名完全免疫儿童的成本很高,主要原因是机构层级的非疫苗成本,这表明免疫规划筹资(无论是国家主导还是捐助驱动)必须具有广阔视角。总体成本的这种显著差异凸显了在不同环境中为儿童提供免疫服务所付出的额外努力。